If, in our study, we merely had focused on the favourable prognostic factors in breast cancer cases, we would have found a RR of 1.46 (0.99–2.17) for developing a hormone receptor-positive breast cancer among users of HRT. The gene discussed is NR4A1; the disease is breast carcinoma.